✦ LIBER ✦
O4-03-08: Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective Aβ42-lowering agent, in Alzheimer’s disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study
✍ Scribed by Gordon K. Wilcock; Sandra E. Black; Judith Haworth; Suzanne B. Hendrix; Mark Laughlin; Kenton H. Zavitz; Daniel Christensen; Sheron Bass; Edward Swabb
- Book ID
- 118462403
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 112 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1552-5260
No coin nor oath required. For personal study only.